Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Ozempic Settles the Obesity Debate: It's Biology Over Willpower
Weight-loss drugs affect the brain in ways that help researchers understand how the body regulates weight. Source link
Pfizer’s Covid Boost Crashes to Earth
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.
Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease
Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle another disease: a rare autoimmune condition that
Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall
The company is rolling out 19 products or new uses within 18 months, CEO Albert Bourla said. Source link
Obesity Drugs Won't Starve These Other Potential Blockbusters
Stocks of developers of fatty liver disease treatments had been on a tear until results from Eli Lilly’s medication were published last week. Source link
OceanGate Suspends Operations After Titan Submersible Implosion That Killed 5
What to Read Next Source link
Moderna, Merck Show Progress Toward Cancer Vaccines
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
Ozempic, Wegovy and Mounjaro Spark a Weight-Loss and Diet Industry Identity Crisis
Weight-loss businesses, which long pushed calorie-counting and willpower, are grappling with the surging popularity of new drugs. Source link
FTC Rejects Illumina's $7 Billion Deal for Cancer-Test Developer Grail
The agency said the combination would hurt competition for cancer-detection tests while raising prices. Source link